Clinical Trial Update: Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features [Phase 2, Phase 3]

View source ↗

Summary

This trial update describes ongoing Phase 2/Phase 3 efforts to refine adjuvant treatment for endometrial cancer based on molecular features.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Leiden University Medical Center | Conditions: Endometrial Cancer | Phase 2, Phase 3 | Status: RECRUITING